The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer: A Randomized Controlled Trial
Open accessAbstract
CONTEXT: Experimental and epidemiological data suggest that vitamin E supplementation may prevent cancer and cardiovascular events. Clinical trials have generally failed to confirm benefits, possibly due to their relatively short duration. OBJECTIVE: To evaluate whether long-term supplementation with vitamin E decreases the risk of cancer, cancer death, and major cardiovascular events. DESIGN, SETTING, AND PATIENTS: A randomized, double-blind, placebo-controlled international trial (the initial Heart Outcomes Prevention Evaluation [HOPE] trial conducted between December 21, 1993, and April 15, 1999) of patients at least 55 years old with vascular disease or diabetes mellitus was extended (HOPE-The Ongoing Outcomes [HOPE-TOO]) between April 16, 1999, and May 26, 2003. Of the initial 267 HOPE centers that had enrolled 9541 patients, 174 centers participated in the HOPE-TOO trial. Of 7030 patients enrolled at these centers, 916 were deceased at the beginning of the extension, 1382 refused participation, 3994 continued to take the study intervention, and 738 agreed to passive follow-up. Median duration of follow-up was 7.0 years. INTERVENTION: Daily dose of natural source vitamin E (400 IU) or matching placebo. MAIN OUTCOME MEASURES: Primary outcomes included cancer incidence, cancer deaths, and major cardiovascular events (myocardial infarction, stroke, and cardiovascular death). Secondary outcomes included heart failure, unstable angina, and revascularizations. RESULTS: Among all HOPE patients, there were no significant differences in the primary analysis: for cancer incidence, there were 552 patients (11.6%) in the vitamin E group vs 586 (12.3%) in the placebo group (relative risk [RR], 0.94; 95% confidence interval [CI], 0.84-1.06; P = .30); for cancer deaths, 156 (3.3%) vs 178 (3.7%), respectively (RR, 0.88; 95% CI, 0.71-1.09; P = .24); and for major cardiovascular events, 1022 (21.5%) vs 985 (20.6%), respectively (RR, 1.04; 95% CI, 0.96-1.14; P = .34). Patients in the vitamin E group had a higher risk of heart failure (RR, 1.13; 95% CI, 1.01-1.26; P = .03) and hospitalization for heart failure (RR, 1.21; 95% CI, 1.00-1.47; P = .045). Similarly, among patients enrolled at the centers participating in the HOPE-TOO trial, there were no differences in cancer incidence, cancer deaths, and major cardiovascular events, but higher rates of heart failure and hospitalizations for heart failure. CONCLUSION: In patients with vascular disease or diabetes mellitus, long-term vitamin E supplementation does not prevent cancer or major cardiovascular events and may increase the risk for heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, despite this, vitamin E did not improve cardiovascular outcomes in a large multicenter trial and actually increased congestive heart failure (201).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [201]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979
Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
Bjelaković, G., Nikolova, D., Simonetti, R. G., & Gluud, C. N. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17138-9 · Cited by 619
Vitamin E in Humans: Demand and Delivery
Traber, M. G., & Sies, H. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.001541 · Cited by 502
Jha, P., Flather, M., Lonn, E., Farkouh, M., & Yusuf, S. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-11-199512010-00009 · Cited by 399
SERUM VITAMIN E AND RISK OF CANCER AMONG FINNISH MEN DURING A 10-YEAR FOLLOW-UP
Knekt, P., Aromaa, A., Maatela, J., Aaran, R., Nikkari, T., Hakama, M., Hakulinen, T. R., Peto, R., Saxén, E., & Teppo, L. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114788 · Cited by 233
Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?
Steinberg, D. H. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92657-7 · Cited by 178
Huang, H.-Y. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf210 · Cited by 173
Research works printed but not linked: 18
- Verlangieri AJ, Bush MJ. Effects of d-␣-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr. 1992;11:131-138.
- Meydani M. Vitamin E. Lancet. 1995;345:170-175.
- Skyrme-Jones RA, O'Brien RC, Berry KL, Meredith IT. Vitamin E supplementation improves endothelial function in type 1 diabetes mellitus: a randomized, pla- cebo-controlled study. J Am Coll Cardiol. 2000;36:94- 100.
- Sigounas G, Anagnostou A, Steiner M. dl-alpha- Tocopherol induces apoptosis in erythroleukemia, pros- tate, and breast cancer cells. Nutr Cancer. 1997;28:30- 35.
- Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer [review]. Cancer Causes Control. 1996;7:157- 177.
- Longnecker MP, Martin-Moreno JM, Knekt P, et al. Serum alpha-tocopherol concentration in relation to sub- sequent colo-rectal cancer: pooled data from five cohorts. J Natl Cancer Inst. 1992;84:430-445.
- Ocke MC, Bueno-de-Mesquita HB, Feskens EJ, van Staveren WA, Kromhout D. Repeated measurements of vegetables, fruits, beta-carotene, and vitamins C and E in relation to lung cancer: the Zutphen Study. Am J Epidemiol. 1997;145:358-365.
- Klein EA, Thompson IM, Lippman SM, et al. SELECT: the next prostate cancer prevention trial: Selenium and Vitamin E Cancer Prevention Trial. J Urol. 2001;166:1311- 1315.
- Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with ␣-tocopherol and -carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90:440-446.
- Li J-Y, Taylor PR, Li B, et al. Nutrition intervention trials in China: multiple incidence and disease-specific mor- tality among adults with esophageal dysplasia. J Natl Can- cer Inst. 1993;85:1492-1498.
- The Alpha-Tocopherol, Beta Carotene Cancer Pre- vention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other can- cers in male smokers. N Engl J Med. 1994;330: 1029-1035.
- Steinberg D, Witzum JL. Is the oxidative modifi- cation hypothesis relevant to human atherosclerosis: do the antioxidant trials conducted to date refute the hypothesis? Circulation. 2002;105:2107-2111.
- The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardio- vascular events in high-risk patients. N Engl J Med. 2000;342:154-160.
- Lonn E, Shaikholeslami R, Yi Q, et al. Effects of ramipril on left ventricular mass and function in car- diovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a sub- study of the HOPE trial. J Am Coll Cardiol. 2004;43: 2200-2206.
- GISSI-Prevenzione Investigators (Gruppo Itali- ano per lo Studio della Sopravvivenza nell'Infracto Miocardico). Dietary supplementation with n-e poly- unsaturated fatty acids and vitamin E after myocar- dial infarction: results of the GISSI-Prevenzione Trial. Lancet. 1999;354:447-455.
- Age-Related Eye Disease Study Group. A ran- domized, placebo-controlled, clinical trial of high-dose supplementation with vitamin C and E and beta-carotene for age-related cataract and vi- sion loss: AREDS Report No. 9. Arch Ophthalmol. 2001; 119:1439-1452.
- Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet. 2001;342:154-160.
- Bowry VW, Ingold KU, Stocker R. Vitamin E in human low-density lipoproteins: when and how this antioxidant becomes a pro-oxidant. Biochem J. 1992; 288:341-344.
Cited by
Sorted by citations
Items 301–400 of 999
Rapid actions of aldosterone in vascular health and disease—friend or foe?
Skøtt, O., Uhrenholt, T. R., Schjerning, J., Hansen, P., Rasmussen, L. E., & Jensen, B. L. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.010 · Cited by 76
Gao, W., Pu, L., Wei, J., Yao, Z., Wang, Y., Shi, T., Zhao, L., Jiao, C., & Guo, C. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0341-9 · Cited by 77
Serafini, M., Villaño, D., Spera, G., & Pellegrini, N. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5602_15 · Cited by 76
“An intervention study in patients with cardiovascular disease or diabetes showed that long-term vitamin E supplementation did not prevent cancer or major cardiovascular events and even increased the risk of heart failure (13).”
BackgroundAldose reductase regulates hyperglycemia-induced HUVEC death via SIRT1/AMPK-α1/mTOR pathway
Pal, P. B., Sonowal, H., Shukla, K., Sk, S., & Ramana, K. V. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0080 · Cited by 76
Interventional study with vitamin E in cardiovascular disease and meta-analysis
Violi, F., Nocella, C., Loffredo, L., Carnevale, R., & Pignatelli, P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.11.027 · Cited by 79
Chan, J. Y. H., & Chan, S. H. H. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.09.005 · Cited by 75
“In practice, all larger, randomized, placebo-controlled antioxidant trials on cancer and cardiovascular events have essentially failed (Steinberg & Witztum, 2002; Vivekananthan et al., 2003; Lee et al., 2005; Lonn et al., 2005; Bjelakovic et al., 2007; Cook et al., 2007; Sesso et al., 2008; Pashkow, 2011).”
Protective Role of Antioxidants in Diabetes-Induced Cardiac Dysfunction
Vassort, G., & Turan, B. (2010) · Cardiovascular Toxicology · doi:10.1007/s12012-010-9064-0 · Cited by 77
“In randomized clinical trials, vitamin E does not bring significant benefit [94, 95 ].”
BackgroundOptimizing the ongoing search for new treatments for Parkinson disease
Tilley, B. C., Palesch, Y. Y., Kieburtz, K. D., Ravina, B. M., Huang, P., Elm, J. J., Shannon, K. M., Wooten, G. F., Tanner, C. M., & Goetz, G. C. (2006) · Neurology · doi:10.1212/01.wnl.0000201251.33253.fb · Cited by 75
Mitochondrial quality control in the diabetic heart
Liang, Q., & Kobayashi, S. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.025 · Cited by 75
Fleshner, N. E., Kapusta, L. R., Donnelly, B. J., Tanguay, S., Chin, J. L., Hersey, K. M., Farley, A., Jansz, K., Siemens, D. R., Trpkov, K., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.0994 · Cited by 73
Kline, K. A., Lawson, K. A., Yu, W., & Sanders, B. G. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(07)76017-x · Cited by 73
Bisping, E. H., Wakula, P., Poteser, M., & Heinzel, F. R. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000126 · Cited by 73
Biesalski, H. K., Grune, T., Tinz, J., Zöllner, I., & Blumberg, J. B. (2010) · Nutrients · doi:10.3390/nu2090929 · Cited by 76
Hamishehkar, H., Ranjdoost, F., Asgharian, P., Mahmoodpoor, A., & Sanaie, S. (2016) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2016.061 · Cited by 72
Ford, E. S., Ajani, U. A., & Mokdad, A. H. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-2-200507190-00010 · Cited by 72
“Furthermore, the Heart Outcomes Prevention Evaluation researchers linked the use of 400 IU of vitamin E per day to an increased risk for congestive heart failure (4).”
BackgroundIs There Any Hope for Vitamin E?
Brown, B. (2005) · JAMA · doi:10.1001/jama.293.11.1387 · Cited by 73
Vignaud, J., Loiseau, C., Hérault, J., Mayer, C., Côme, M., Martin, I., & Ulmann, L. (2023) · Antioxidants · doi:10.3390/antiox12051050 · Cited by 72
“However, studies report that long-term vitamin E supplementation may increase the risk of heart failure in patients with vascular disease or diabetes mellitus [100].”
BackgroundThe Antioxidant Paradox in Diabetes Mellitus
Sheikh‐Ali, M., Chehade, J. M., & Mooradian, A. D. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181b7badf · Cited by 73
Potential use of antioxidants for the treatment of chronic inflammatory diseases
Blagov, A. V., Summerhill, V. I., Sukhorukov, V. N., Zhigmitova, E. B., Postnov, A. Y., & Orekhov, A. N. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1378335 · Cited by 80
“However, the human trials produced inconclusive results; some trials have demonstrated positive effects (Imamura et al., 2017), while others revealed either detrimental effects (Lonn et al., 2005) or no effects at all (van der Made et al., 2015).”
ResultSafety of Vitamins and Minerals: Controversies and Perspective
Soni, M. G., Thurmond, T. S., Miller, E. R., Spriggs, T. L. B., Bendich, A., & Omaye, S. T. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq293 · Cited by 73
“02 or 2% higher risk for the vitamin E–supplemented group compared with placebo controls (Lonn et al., 2005).”
BackgroundVitamins in aging, health, and longevity
Thomas, D. R. (2006) · Clinical Interventions in Aging · doi:10.2147/ciia.2006.1.1.81 · Cited by 71
Godbout, J. P., Berg, B. M., Krzyszton, C. P., & Johnson, R. W. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.08.003 · Cited by 72
Role of vitamins in gastrointestinal diseases
Masri, O. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i17.5191 · Cited by 75
Ngwenyama, N., Kirabo, A., Aronovitz, M. J., Velázquez, F., Carrillo-Salinas, F. J., Salvador, A. M., Nevers, T. A., Amarnath, V., Tai, A., Blanton, R. M., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.051889 · Cited by 70
Antioxidant supplements for preventing gastrointestinal cancers
Bjelaković, G., Nikolova, D., Simonetti, R., & Gluud, C. N. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004183.pub2 · Cited by 70
Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts
Eng, P. C., Forlano, R., Tan, T., Manousou, P., Dhillo, W. S., & Izzi‐Engbeaya, C. N. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100835 · Cited by 75
Papaioannou, D. E., Cooper, K. L., Carroll, C., Hind, D., Squires, H., Tappenden, P., & Logan, R. F. (2010) · Colorectal Disease · doi:10.1111/j.1463-1318.2010.02289.x · Cited by 69
Li, X.-H., Li, C., Zhi-gang, X., Hu, J., Lu, J.-M., Tian, R.-B., & Jia, W. P. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6415-z · Cited by 68
Beyond vitamin E supplementation: An alternative strategy to improve vitamin E status
Frank, J. (2005) · Journal of Plant Physiology · doi:10.1016/j.jplph.2005.04.017 · Cited by 68
Medical Management of Peyronie's Disease
Hellstrom, W. J. G. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.006221 · Cited by 68
Epidemiological and Clinical Studies of Nutrition
Gibson, T. M., Ferrucci, L. M., Tangrea, J. A., & Schatzkin, A. G. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.05.011 · Cited by 68
Andersson, H., Demaegdt, H., Vauquelin, G., Lindeberg, G., Karlén, A., Hallberg, M., Erdélyi, M., & Hallberg, A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100793t · Cited by 68
The role of vitamins and minerals in modulating the expression of microRNA
Beckett, E., Yates, Z. R., Veysey, M. J., Duesing, K., & Lucock, M. D. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000043 · Cited by 72
“However, not all studies have drawn the same conclusions, with others finding a neutral((138,139)) or detrimental effect on cancer and heart disease risk((140,141)).”
ResultNatural Products for Cancer Prevention
Greenlee, H. (2012) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2011.11.004 · Cited by 68
Oxidative balance score and risk of prostate cancer: Results from a case-cohort study
Agalliu, I., Kirsh, V. A., Kreiger, N., Soskolne, C. L., & Rohan, T. E. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.11.002 · Cited by 67
“b-Carotene, vitamin C, vitamin E, b-cryptoxanthin, lycopene, lutein and selenium were included in the score since they have well-established antioxidant properties [51–56].”
BackgroundRegulatory role of vitamins E and C on extracellular matrix components of the vascular system
Villacorta, L., Azzi, A., & Zingg, J.-M. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.05.002 · Cited by 65
Remely, M., Ferk, F., Sterneder, S., Setayesh, T., Kepčija, T., Roth, S., Noorizadeh, R., Greunz, M., Rebhan, I., Wagner, K., et al. (2017) · Nutrients · doi:10.3390/nu9060607 · Cited by 67
“Adverse effects were also shown, such as increased risk for heart failure [59] or increased risk of hemorrhagic stroke [60].”
BackgroundEstimation of total antioxidant capacity from diet and supplements in US adults
Yang, M., Chung, S.-J., Chung, C. E., Kim, D.-O., Song, W. O., Koo, S. I., & Chun, O. K. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511000109 · Cited by 65
Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease
Steven, S., Münzel, T. F., & Daiber, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818185 · Cited by 68
“However, antioxidants have failed to show any therapeutic benefit in most large clinical trials that were conducted according to modern standards [46], such as HOPE (Heart Outcome Prevention Evaluation) and HOPE-TOO (Heart Outcome Prevention Evaluation—”
Mata-Granados, J. M., de Castro, M. D. L., & Gómez, J. M. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.02.003 · Cited by 66
Vitamin E and Risk of Cardiovascular Diseases: A Review of Epidemiologic and Clinical Trial Studies
Gonzalez, Z. C., Drogan, D., Weikert, C., & Boeing, H. (2010) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390802304230 · Cited by 69
“…et al., 2000; Salonen et al., 2003), and the CLAS (Hodis et al., 1995; Azen et al., 1996) have suggested a beneficial effect, other research groups did not find any association: VEAPS (Hodis et al., 2002), SECURE (Lonn et al., 2001), WAVE (Magliano et al., 2006), and MAVET (Waters et al., 2002).”
ResultInfluentialRole of Estrogen in Type 1 and Type 2 Diabetes Mellitus: A Review of Clinical and Preclinical Data
Paoli, M. D., & Werstuck, G. H. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.01.003 · Cited by 66
Frank, J., Budek, A. Z., Lundh, T., Parker, R. S., Swanson, J. E., Lourenço, C. F., Gago, B., Laranjinha, J. A. N., Vessby, B. O., & Kamal‐Eldin, A. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600291-jlr200 · Cited by 65
“associated with increases in all-cause mortality (9) and heart failure (10).”
BackgroundAldosterone and cardiovascular disease: the heart of the matter
He, B. J., & Anderson, M. E. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.09.004 · Cited by 66
Absorption, Transport, and Bioavailability of Vitamin E and its Role in Pregnant Women
Gagné, A., Wei, S. Q., Fraser, W. D., & Julien, P. (2009) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34118-4 · Cited by 65
The metabolic syndrome and endothelial dysfunction: Common highway to type 2 diabetes and CVD?
Diamant, M., & Tushuizen, M. E. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0061-4 · Cited by 64
“The use of antioxidants and vitamins, although promising in short-term studies assessing surrogate end points [51], has so far not yielded the expected benefit in long-term prospective trials [ 52 ,53].”
BackgroundRole of Antioxidants in the Prevention of Cancer
Bennett, L. L., Rojas, S., & Seefeldt, T. M. (2012) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2012.06.001 · Cited by 64
Birjmohun, R. S., Vergeer, M., Stroes, E. S. G., Sandhu, M. S., Ricketts, S. L., Tanck, M. W. T., Wareham, N. J., Jukema, J. W., Kastelein, J. J. P., Khaw, K., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006809 · Cited by 62
Role of Oxidants and Antioxidants in Atherosclerosis: Results of In Vitro and In Vivo Investigations
Siekmeier, R., Steffen, C., & März, W. (2007) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248407299519 · Cited by 64
Safety Considerations and Potential Interactions of Vitamins: Should Vitamins Be Considered Drugs?
Rogovik, A. L., Vohra, S., & Goldman, R. D. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m238 · Cited by 65
Mass spectrometry in nutrition: Understanding dietary health effects at the molecular level
Kussmann, M., Affolter, M., Nagy, K., Holst, B., & Fay, L. B. (2007) · Mass Spectrometry Reviews · doi:10.1002/mas.20147 · Cited by 64
“This broad functionality drives research efforts to further investigate the role of vitamin E in the prevention of cardiovascular diseases, cancer, diabetes and Alzheimer’s disease (Lonn et al., 2005; Morris et al., 2005; Hino et al., 2006).”
BackgroundSottero, B., Gargiulo, S., Russo, I., Barale, C., Poli, G., & Cavalot, F. L. (2015) · Medicinal Research Reviews · doi:10.1002/med.21349 · Cited by 65
Nutraceuticals for older people: Facts, fictions and gaps in knowledge
González‐Sarrías, A., Larrosa, M., García‐Conesa, M., Tomás-Barberán, F. A., & Espín, J. C. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.05.006 · Cited by 70
“rial (SELECT) reported that the daily supplementation of vitamin (400 IU for a mean follow-up of 7 years) in healthy elderly men or t high CVD risk, respectively, had no clear impact on fatal and nonatal cancers, or deaths [16] or against prostate cancer incidence 17].”
BackgroundInfluentialVitamin and mineral use and risk of prostate cancer: the case–control surveillance study
Zhang, Y., Coogan, P. F., Palmer, J. R., Strom, B. L., & Rosenberg, L. A. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9282-y · Cited by 63
“One clinical trial [9] and two observational studies [10, 22] found that the use of vitamin E supplements was inversely associated with the risk of prostate cancer but other studies showed no association [11, 13-16, 27].”
BackgroundSelin, J. Z., Rautiainen, S., Lindblad, B. E., Morgenstern, R., & Wolk, A. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws279 · Cited by 64
“On the contrary, studies have reported potential harmful effects of high-dose antioxidant supplements, such as increased risk of mortality (3, 4), heart failure (5), and some cancer types (6–8).”
BackgroundTrace Elements, Heavy Metals and Vitamin Levels in Patients with Coronary Artery Disease
Çebi, A., Kaya, Y., Güngör, H., Demir, H., Yoruk, I. H., Söylemez, N., Güneş, Y., & Tuncer, M. (2011) · International Journal of Medical Sciences · doi:10.7150/ijms.8.456 · Cited by 63
“Levels of tocopherol were reported to be decreased in coronary artery disease (23).”
BackgroundPatel, V., Rink, C. L., Gordillo, G. M., Khanna, S., Gnyawali, U. S., Roy, S., Shneker, B. F., Ganesh, K., Phillips, G. S., More, J. L., et al. (2012) · Journal of Nutrition · doi:10.3945/jn.111.151902 · Cited by 63
Distinct Regulatory Effects of Myeloid Cell and Endothelial Cell NAPDH Oxidase 2 on Blood Pressure
Sag, C. M., Schnelle, M., Zhang, J., Murdoch, C. E., Kossmann, S., Protti, A., Santos, C. X. C., Sawyer, G. J., Zhang, X., Mongue‐Din, H., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.023877 · Cited by 62
van Wijngaarden, P., & Qureshi, S. H. (2008) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2008.00305.x · Cited by 63
Adverse effects of vitamin E by induction of drug metabolism
Brigelius‐Flohé, R. (2007) · Genes & Nutrition · doi:10.1007/s12263-007-0055-0 · Cited by 62
Vitamin Status and Needs for People with Stages 3-5 Chronic Kidney Disease
Steiber, A. L., & Kopple, J. D. (2011) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2010.12.004 · Cited by 62
“This increased risk was associated with vitamin E intakes as low as 150 IU/day (136 mg/day).(61,62) These studies, taken together, suggest that among people at high risk for cardiovascular events, supplemental vitamin E may not be indicated in the general population or in nondialysis CKD patients.”
BackgroundBlood Pressure in Acute Stroke
Bath, P. M., Appleton, J. P., Krishnan, K., & Sprigg, N. (2018) · Stroke · doi:10.1161/strokeaha.118.021254 · Cited by 62
Takahashi, S., Takeshita, K., Seeni, A., Sugiura, S., Tang, M., Sato, S., Kuriyama, H., Nakadate, M., Abe, K., Maeno, Y., et al. (2009) · The Prostate · doi:10.1002/pros.20915 · Cited by 61
Chemoprevention of Lung Cancer
Szabo, E. M., Mao, J. T., Lam, S. C., Reid, M. E., & Keith, R. L. (2013) · CHEST Journal · doi:10.1378/chest.12-2348 · Cited by 65
Hamblin, M., Smith, H., & Hill, M. F. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.07.002 · Cited by 61
Evolution of medical treatment for endometriosis: back to the roots?
Wieser, F., Cohen, M., Gaeddert, A., Yu, J., Burks-Wicks, C., Berga, S. L., & Taylor, R. N. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm015 · Cited by 76
“Data from the HOPE and HOPE-TOO trials showed that vitamin E did not decrease fatal or non-fatal cancer (Lonn et al., 2005).”
Dietrich, M., Jacques, P. F., Pencina, M. J., Lanier, K. J., Keyes, M. J., Jasuja, G. K., Wolf, P. A., D’Agostino, R. B., & Vasan, R. S. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.019 · Cited by 60
Unleashing the untold and misunderstood observations on vitamin E
Gee, P. T. (2010) · Genes & Nutrition · doi:10.1007/s12263-010-0180-z · Cited by 60
Evaluation and Management of the Elderly Patient Presenting with Cognitive Complaints
Hildreth, K. L., & Church, S. D. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.11.006 · Cited by 66
Targeting NOS as a therapeutic approach for heart failure
Tang, L., Wang, H., & Ziolo, M. T. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.013 · Cited by 60
Catania, A. S., de Barros, C. R., & Ferreira, S. R. G. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000500008 · Cited by 60
Khatami, P. G., Soleimani, A., Sharifi, N., Aghadavod, E., & Asemi, Z. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.02.021 · Cited by 62
“0 years did not 219 prevent cancer or major cardiovascular events while increased the risk of heart failure [24].”
BackgroundVitamin E Supplementation in Cardiovascular Disease and Cancer Prevention: Part 1
Pham, D. Q., & Plakogiannis, R. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g211 · Cited by 59
Mitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets
Apostolova, N., Vezza, T., Muntané, J., Rocha, M., & Víctor, V. M. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0016 · Cited by 60
Weiss, N., Ide, N., Abahji, T. N., Nill, L., Keller, C., & Hoffmann, U. (2006) · Journal of Nutrition · doi:10.1093/jn/136.3.750s · Cited by 59
Reagan‐Shaw, S., Nihal, M., Ahsan, H., Mukhtar, H., & Ahmad, N. (2008) · The Prostate · doi:10.1002/pros.20824 · Cited by 60
Fu, J.-Y., Qian, L.-B., Zhu, L.-G., Liang, H.-T., Tan, Y., Lu, H., Lü, J., Wang, H., & Xia, Q. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.08.025 · Cited by 61
Cangemi, R., Loffredo, L., Carnevale, R., Perri, L., Patrizi, M. P., Sanguigni, V., Pignatelli, P., & Violi, F. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm565 · Cited by 59
Smit, L. A., Katan, M., Wanders, A. J., & Basu, S. (2011) · Journal of Nutrition · doi:10.3945/jn.110.134668 · Cited by 59
The Impact of Nutrition on Cognition in the Elderly
Dyk, K. V., & Sano, M. C. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9241-5 · Cited by 63
Qin, F., Chen, Y., Patel, R., Liu, W., & Dong, E. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.019 · Cited by 60
Wright, J. W., & Harding, J. W. (2008) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320308099084 · Cited by 62
Antioxidants for prostate cancer chemoprevention: Challenges and opportunities
Thapa, D., & Ghosh, R. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.027 · Cited by 58
“Several studies have indicated that large doses of antioxidants can increase the risk of cancer and other diseases [63,81,84,92].”
BackgroundVitamin E and Non-Communicable Diseases: A Review
Ciarcià, G., Bianchi, S., Tomasello, B., Acquaviva, R., Malfa, G. A., Николаевна, Н. И., Mantia, A. L., & Giacomo, C. D. (2022) · Biomedicines · doi:10.3390/biomedicines10102473 · Cited by 58
Vitamin E and memantine in Alzheimer's disease: Clinical trial methods and baseline data
Dysken, M. W., Guarino, P., Vertrees, J. E., Asthana, S., Sano, M. C., Llorente, M. D., Pallaki, M., Love, S. B., Schellenberg, G. D., McCarten, J. R., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.014 · Cited by 62
“Caregivers and patients were queried in general about adverse experiences at each contact, and were queried specifically about patient falls, syncope, and congestive heart failure diagnoses resulting from concerns from previous studies that these events could be related to high-dose alpha-tocopherol treatment [5,19].”
BackgroundMurzaku, E. C., Bronsnick, T., & Rao, B. K. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.06.016 · Cited by 60
Use of pentoxifylline and tocopherol in radiation-induced fibrosis and fibroatrophy
Patel, V., & McGurk, M. (2016) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2016.11.323 · Cited by 60
Dietary Antioxidants: Potential Anticancer Agents
Wu, X., Cheng, J., & Wang, X. (2017) · Nutrition and Cancer · doi:10.1080/01635581.2017.1299872 · Cited by 58
“deaths between individuals randomly assigned to take 400 IU/day vitamin E or a placebo (35).”
BackgroundEffects of dietary RRR α-tocopherol vs all-racemic α-tocopherol on health outcomes
Ranard, K. M., & Erdman, J. W. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux067 · Cited by 60
Redox Systems Biology of Nutrition and Oxidative Stress
Dennis, K. K., Go, Y., & Jones, D. P. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy306 · Cited by 60
Risk of Mortality with Vitamin E Supplements: The Cache County Study
Hayden, K. M., Welsh-Bohmer, K. A., Wengreen, H. J., Zandi, P. P., Lyketsos, C. G., & Breitner, J. C. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.039 · Cited by 58
Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway
Chen, X., Wan, W., Guo, Y., Ye, T., Fo, Y., Sun, Y., Qu, C., Yang, B., & Zhang, C. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00363-7 · Cited by 57
Dietary modification and supplementation for the treatment of age-related macular degeneration
Broadhead, G., Grigg, J., Chang, A., & McCluskey, P. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv005 · Cited by 59
Capellini, V. K., Celotto, A. C., Baldo, C. F., Olivon, V. C., Viaro, F., Rodrigues, A. J., & Évora, P. R. B. (2010) · Current Vascular Pharmacology · doi:10.2174/157016110791330834 · Cited by 57
Antioxidant Supplementation on Cancer Risk and During Cancer Therapy: An Update
Özben, T. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666141209160918 · Cited by 57
The Potential Physiological Role of γ-Tocopherol in Human Health: A Qualitative Review
Thompson, M. D., & Cooney, R. V. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1653472 · Cited by 59
“sisted up to 7 years after the initial study period (140).”
BackgroundSupplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment
Sunkara, A., & Raizner, A. E. (2019) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-15-3-179 · Cited by 58
Associations between α-Tocopherol, β-Carotene, and Retinol and Prostate Cancer Survival
Watters, J. L., Gail, M. H., Weinstein, S. J., Virtamo, J. R. K., & Albanes, D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4640 · Cited by 56
Androgen Deprivation Therapy: Monitoring and Managing the Complications
Higano, C. S. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.03.013 · Cited by 56
Natural Products for Cancer Prevention: Clinical Update 2016
Sanders, K., Moran, Z. R., Shi, Z., Paul, R., & Greenlee, H. (2016) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2016.06.001 · Cited by 56
Metadata
- Authors
- The HOPE and HOPE-TOO Trial Investigators
- Affiliations
- Population Health Research Institute (CA)
- Corresponding author
- The HOPE and HOPE-TOO Trial Investigators
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-03-16
- Volume
- 293
- Issue
- 11
- Pages
- 1338
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1678920698
- Cited by
- 1,209
- References
- 20
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 31 · 2023: 35 · 2022: 35 · 2021: 34 · 2020: 45 · 2019: 37 · 2018: 22 · 2017: 44 · 2016: 48 · 2015: 56 · 2014: 95 · 2013: 70 · 2012: 87
- FWCI
- 58.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council Canada
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- vitamin E supplementation, long-term supplementation, cancer incidence, cancer mortality, cardiovascular events, myocardial infarction, stroke, cardiovascular mortality, heart failure, unstable angina, revascularization, older adults, vascular disease, diabetes mellitus
- MeSH terms
- Aged, Antioxidants, Cardiovascular Diseases, Diabetes Mellitus, Double-Blind Method, Female, Humans, Male, Middle Aged, Neoplasms, Risk, Vascular Diseases, Dietary Supplements, alpha-Tocopherol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review